carnosine has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Han, SB; Jang, EH; Kang, JH; Kim, JS; Kim, KH; Ko, JH; Oh, YM; Park, CS; Pie, JE; Shin, DW | 1 |
| Afshin-Majd, S; Baluchnejadmojarad, T; Khalili, M; Mehranmehr, N; Roghani, M | 1 |
| Kawahara, M; Kobayashi, N; Kubota, M; Shimoda, M; Sugizaki, T; Tanaka, KI | 1 |
3 other study(ies) available for carnosine and oxidopamine
| Article | Year |
|---|---|
Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by l-carnosine in SH-SY5Y cells.
Topics: Carnosine; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Eukaryotic Initiation Factor-2; Heat-Shock Proteins; Humans; Neuroprotective Agents; Neurotoxins; Oxidopamine; Phosphorylation; Proto-Oncogene Proteins c-jun; Reactive Oxygen Species; RNA Splicing; Stress, Physiological; Time Factors | 2009 |
Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.
Topics: Animals; Carnosine; Male; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Treatment Outcome | 2015 |
Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's disease.
Topics: Animals; Carnosine; Cell Death; Cell Line; Cytokines; Gene Expression Regulation; Humans; MAP Kinase Signaling System; Mice; Models, Biological; Oxidative Stress; Oxidopamine; Parkinson Disease; Reactive Oxygen Species | 2020 |